Mucocutaneous lymph node syndrome [Kawasaki]


mucocutaneous lymph node syndrome: Kawasaki disease (KD) is a febrile, systemic, self-limiting vasculitis affecting children and characterized by inflammation in the medium sized vessels associated with coronary arterial aneurysms (CAA) that may be life threatening when untreated. KD is the most common cause of acquired heart disease in children in developed countries and is a risk factor for ischemic heart disease in adulthood.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 M30.3
Hospital discharge: ICD-9 4461
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 M30.3
Cause of death: ICD-9 4461
Cause of death: ICD-8 $!$


diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9


diagram downward connector

Check minimum number of events None


diagram downward connector

Include endpoints None


diagram downward connector

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 M30
Name in latin Syndroma mucocutaneum lymphonodorum (Kawasaki)

Summary Statistics

Key figures

All Female Male
Number of individuals 41 22 19
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 20.92 18.00 24.29


Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: M13_KAWASAKI – Mucocutaneous lymph node syndrome [Kawasaki]
GWS hits:

Survival analyses between endpoints


before Mucocutaneous lymph node syndrome [Kawasaki]
after Mucocutaneous lymph node syndrome [Kawasaki]

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Mucocutaneous lymph node syndrome [Kawasaki]